Evaluation of a new combination oral contraceptive: lynestrenol-mestranol (Lyndiol).
D000293:Adolescent; D000328:Adult; D001777:Blood Coagulation / Q000187:drug effects; D001835:Body Weight; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004717:Endometrium / Q000187:drug effects; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000494:pharmacology*; D008598:Menstruation; D008656:Mestranol / Q000494:pharmacology*; D008875:Middle Aged; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy; D011276:Pregnanediol / Q000652:urine
D003276:Contraceptives, Oral; D008656:Mestranol; D011276:Pregnanediol; D008234:Lynestrenol